Smart drugs to fight cancer
OpenProtein.AI expands partnership with Boehringer Ingelheim on AI-driven antibody discovery
New biomarker helps assess aggression of glioblastoma
Protein helps cancer cells survive treatment
Base to Base biotech podcast 45: Chronic pain, urology, Affibody molecules and radioligand therapy
Johnson & Johnson prostate cancer drug receives CHMP positive opinion
Breakthru Medicine emerges from stealth to develop cancer drugs
FDA Rare Pediatric Disease designation for mucopolysaccharidosis Type II treatment
CIRM approves $100m plan to accelerate genetic therapies for patients with rare diseases
Researchers develop more reliable platform to test antibody medicines
Positive topline results from acne study
Sarbecovirus vaccine trial starts